Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 198

1.

MUC1 expression in thymic epithelial tumors: MUC1 may be useful marker as differential diagnosis between type B3 thymoma and thymic carcinoma.

Kaira K, Murakami H, Serizawa M, Koh Y, Abe M, Ohde Y, Takahashi T, Kondo H, Nakajima T, Yamamoto N.

Virchows Arch. 2011 May;458(5):615-20. doi: 10.1007/s00428-011-1041-x. Epub 2011 Jan 21.

PMID:
21253760
2.

CD98 expression is associated with the grade of malignancy in thymic epithelial tumors.

Kaira K, Takahashi T, Abe M, Akamatsu H, Nakagawa K, Ohde Y, Okumura T, Murakami H, Tsuya A, Nakamura Y, Naito T, Kondo H, Nakajima T, Endo M, Yamamoto N.

Oncol Rep. 2010 Oct;24(4):861-7.

PMID:
20811665
3.

Correlation between tumor angiogenesis and invasiveness in thymic epithelial tumors.

Tomita M, Matsuzaki Y, Edagawa M, Maeda M, Shimizu T, Hara M, Onitsuka T.

J Thorac Cardiovasc Surg. 2002 Sep;124(3):493-8.

PMID:
12202865
4.
5.

Expression of proteasome subunit β5t in thymic epithelial tumors.

Yamada Y, Tomaru U, Ishizu A, Kiuchi T, Marukawa K, Matsuno Y, Kasahara M.

Am J Surg Pathol. 2011 Sep;35(9):1296-304. doi: 10.1097/PAS.0b013e3182237f5d.

PMID:
21836487
6.

Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma: diagnostic utility of hypoxic marker, GLUT-1, in thymic epithelial neoplasms.

Kojika M, Ishii G, Yoshida J, Nishimura M, Hishida T, Ota SJ, Murata Y, Nagai K, Ochiai A.

Mod Pathol. 2009 Oct;22(10):1341-50. doi: 10.1038/modpathol.2009.105. Epub 2009 Jul 31.

7.

Expression of thymidylate synthase, orotate phosphoribosyltransferase and dihydropyrimidine dehydrogenase in thymic epithelial tumors.

Kaira K, Serizawa M, Koh Y, Miura S, Kaira R, Abe M, Nakagawa K, Ohde Y, Okumura T, Murakami H, Tsuya A, Nakamura Y, Naito T, Takahashi T, Kondo H, Nakajima T, Endo M, Yamamoto N.

Lung Cancer. 2011 Dec;74(3):419-25. doi: 10.1016/j.lungcan.2011.04.001. Epub 2011 May 7.

PMID:
21550686
8.

Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma.

Pan CC, Chen PC, Chou TY, Chiang H.

Hum Pathol. 2003 Nov;34(11):1155-62.

PMID:
14652817
9.

L-type amino acid transporter 1 (LAT1) is frequently expressed in thymic carcinomas but is absent in thymomas.

Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M.

J Surg Oncol. 2009 Jun 1;99(7):433-8. doi: 10.1002/jso.21277.

PMID:
19347882
10.

Proliferative activity and apoptosis in thymic epithelial neoplasms.

Hiroshima K, Iyoda A, Toyozaki T, Supriatna Y, Shibuya K, Shimamura F, Haga Y, Yoshida S, Fujisawa T, Ohwada H.

Mod Pathol. 2002 Dec;15(12):1326-32.

11.

Expression of apoptosis-related markers and HER-2/neu in thymic epithelial tumours.

Pan CC, Chen PC, Wang LS, Lee JY, Chiang H.

Histopathology. 2003 Aug;43(2):165-72.

PMID:
12877732
12.

Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors.

Kaira K, Endo M, Abe M, Nakagawa K, Ohde Y, Okumura T, Takahashi T, Murakami H, Tsuya A, Nakamura Y, Naito T, Hayashi I, Serizawa M, Koh Y, Hanaoka H, Tominaga H, Oriuchi N, Kondo H, Nakajima T, Yamamoto N.

J Clin Oncol. 2010 Aug 10;28(23):3746-53. doi: 10.1200/JCO.2009.27.4662. Epub 2010 Jul 12.

13.
14.

The MIC2 antibody 013. Practical application for the study of thymic epithelial tumors.

Chan JK, Tsang WY, Seneviratne S, Pau MY.

Am J Surg Pathol. 1995 Oct;19(10):1115-23.

PMID:
7573670
15.

Diagnostic and clinical significance of KIT(CD117) expression in thymic epithelial tumors in China.

Song N, Chen G, Zhang P, Liu M, He WX, Jiang GN.

Asian Pac J Cancer Prev. 2012;13(6):2745-8.

16.

Expression of c-Jun, p73, Casp9, and N-ras in thymic epithelial tumors: relationship with the current WHO classification systems.

Ma Y, Li Q, Cui W, Miao N, Liu X, Zhang W, Zhang C, Wang J.

Diagn Pathol. 2012 Sep 14;7:120. doi: 10.1186/1746-1596-7-120.

17.

Expression of neurotrophin receptors in surgically resected thymic epithelial tumors.

Kim DJ, Yang WI, Kim SH, Park IK, Chung KY.

Eur J Cardiothorac Surg. 2005 Oct;28(4):611-6.

PMID:
16125946
18.

Diagnostic utility of thymic epithelial markers CD205 (DEC205) and Foxn1 in thymic epithelial neoplasms.

Nonaka D, Henley JD, Chiriboga L, Yee H.

Am J Surg Pathol. 2007 Jul;31(7):1038-44.

PMID:
17592270
19.

Utility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors.

Endo M, Nakagawa K, Ohde Y, Okumura T, Kondo H, Igawa S, Nakamura Y, Tsuya A, Murakami H, Takahashi T, Yamamoto N, Ito I, Kameya T.

Lung Cancer. 2008 Sep;61(3):350-5. doi: 10.1016/j.lungcan.2008.01.003. Epub 2008 Mar 4.

PMID:
18304691
20.

Expression of podoplanin in thymoma: its correlation with tumor invasion, nodal metastasis, and poor clinical outcome.

Tateyama H, Sugiura H, Yamatani C, Yano M.

Hum Pathol. 2011 Apr;42(4):533-40. doi: 10.1016/j.humpath.2010.08.012. Epub 2011 Jan 14.

PMID:
21237498
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk